Serdar Inci
  1. Associate

Dr. Inci is an associate in Davis Polk's Corporate Department, practicing in the London office. His practice focuses on advising corporate and investment banking clients on strategic corporate transactions and international securities offerings (debt and equity) including IPOs, follow-on offerings and other SEC registered deals, Rule 144A and Regulation S transactions and other private placements.

Work Highlights

  • Centogene on its $56 million IPO on Nasdaq
  • EQT on its $1.4 billion IPO on Nasdaq Stockholm
  • SEAS-NVE on its DKK 5.4 billion (approx. $800 million) secondary block sale of shares in Ørsted
  • Centogene on its $49 million follow-on offering
  • Ferguson on its $600 million Rule 144A and Reg. S notes offering
  • A leading German automobile manufacturer on various Rule 144A and Reg. S notes offerings, totaling U.S. $9 billion
  • The underwriters on Deutsche Bank's $500 million SEC-registered offering of subordinated Tier 2 notes
  • The underwriters on British American Tobacco's SEC-registered $2.4 billion notes offering
  • The underwriters on Oesterreichische Kontrollbank’s SEC-registered $1.5 billion notes offering
  • The underwriters on the $1.25 billion SEC-registered additional tier 1 notes offering by the largest bank in Germany and one of the largest financial institutions in Europe and the world
  • Lazard as financial adviser and sponsor and Numis Securities as financial adviser and sole bookrunner on the Bovis Homes/Galliford £1.075 billion acquisition
  • The investment banking arm of a Scottish bank on the establishment of its $5 billion U.S. commercial paper program
  • A Swiss multinational healthcare company on the update of its $7.5 billion U.S. commercial paper program

Of Note

  • Visiting Scholar, Harvard Law School, Program on Corporate Governance, 2016-2017

Professional History

  • Davis Polk since 2018

Practice Focus

Bar Admissions

  • State of New York

Education

  • J.D., University of Cologne, 2014
    • Dean's Award for Academic Excellence
    • Third in Class
  • Ph.D., University of Cologne, 2017
    • Ph.D. Scholarship
    • Studienstiftung Scholarship
    • summa cum laude
    • Editor-In-Chief, Cologne Business Law Review
  • LL.M., Columbia Law School, 2018
    • DAAD Scholarship
    • Dr. Theo Waigel Scholarship
    • Dr. Walter Oppenhoff Scholarship
    • ERP-Scholarship (German Rhodes)
    • Senior Editor, Columbia Journal of European Law

Languages

  • German
  • French
  • Turkish